Novartis breaks ground on $500m Russian facility

June 21, 2011
Manufacturing and Production Novartis, Russia, pharma manufacturing news

Novartis has started construction of its new pharmaceutical manufacturing plant in St. Petersburg, Russia.The company has broken ground on the …

Dr Reddy’s API plant in Mexico under FDA scrutiny

June 21, 2011
Manufacturing and Production APIs, Dr Reddy's, FDA, GMP violations, pharma manufacturing news

Indian drugmaker Dr Reddy’s Laboratories has been sent a warning letter by the US FDA after a manufacturing facility in …

interlace_global_john_gill

Interlace Global Group appoints ten new staff

June 21, 2011
Medical Communications apppointment, medical communications

Interlace Global Group has expanded the client services and editorial teams at its twin companies Wells Healthcare and Interlace Global …

Smelly Risperdal adds to J&J’s recall tally

June 20, 2011
Manufacturing and Production John Lechleiter, pharma manufacturing news, recalls

Johnson & Johnson continues to be plagued by product recalls, with the latest involving two lots of its schizophrenia drug …

NICE guideline helping to cut referrals

June 20, 2011
GSK, NICE, bph

A NICE guideline on treating lower urinary tract symptoms (LUTS) in men is helping to cut referrals to urologists, thereby …

rocheroof

Mid-stage trial boost for Roche skin cancer drug vismodegib

June 20, 2011
Research and Development Cancer, Roche, skin cancer, vismodegib

Rocheโ€™s novel skin cancer drug vismodegib has met its primary endpoint in a phase II trial. Vismodegib is an investigational, …

GlaxoSmithKline expands Canadian manufacturing plant

June 20, 2011
Manufacturing and Production GSK, pharma manufacturing news

GlaxoSmithKline has set aside almost ยฃ19 million ($31 million) to expand a manufacturing facility in Ontario, Canada, creating 70 additional …

Cost-effectiveness assessment body NICE

NICE reprieved by government U-turn

June 20, 2011
Sales and Marketing Health and Social Care Bill, NICE, value-based pricing

The government has performed an unexpected U-turn by allowing NICE to retain its powers to decide which new drugs the …

Double Helix appoints Sarah Frere-Cook and Ginevra Drinka

June 20, 2011
Medical Communications, Sales and Marketing appointment, medical communications, sales and marketing

Double Helix has boosted its London-based strategic market research team with two new appointments. Sarah Frere-Cook joins as a research …

Actelion plans biotech start-up

June 20, 2011
Research and Development Actelion, biotech

Swiss biopharmaceutical company Actelion is planning to launch a biotech start-up that would run separately from the main company. It …

Europe slower than US to approve new cancer drugs

June 17, 2011
Sales and Marketing EMA, FDA, FDA approvals, new drug approvals

The European Medicines Agency approves fewer new oncology drugs than its US counterpart and takes nearly twice as long to …

Stem cell trial aims to cure macular degeneration

June 17, 2011
Research and Development AMD, Advanced Cell Technology, Stargardtโ€™s Macular Dystrophy, Stem cells, stem cell

A groundbreaking trial to explore the use of stem cells to treat macular degeneration has been launched. US company Advanced …

hrw_esme_holt

HRW appoints Esme Holt and Rob Egerton

June 17, 2011
Medical Communications, Sales and Marketing appointment, medical communications, sales and marketing

Oxfordshire, UK-based market research company HRW has made two new appointments to its senior team. Esme Holt, who joined HRW …

New mixed media comms agency launched

June 17, 2011
Medical Communications medical communications, medical communications agency

A new UK med comms agency aiming to bring fresh ideas to pharma with a special emphasis on new media …

Service Insight: Emotion – at the heart of the creative process

June 17, 2011
Medical Communications Service Insight, advertising, creativity

SERVICE INSIGHTI once read an article about how advertising works which described an incident where a man was speared through …

Rocheโ€™s Avastin (bevacizumab)

NHS failed to use extra cancer drug funds

June 17, 2011
Sales and Marketing Cancer, Cancer Drugs Fund, Erbitux, avastin

The million pound fund set up to increase NHS uptake of new cancer drugs was widely underused, with just over …

AstraZeneca

AZ establishes predictive science centre in Russia

June 17, 2011
Research and Development AstraZeneca, Russia, predictive science

AstraZeneca is moving further into Russia with the establishment in St. Petersburg of a facility which aims to better assess …

Lundbeck to file alcoholism pill this year

June 16, 2011
Sales and Marketing Biotie, Lundbeck, alcohol

Lundbeck plans to submit its alcohol dependency treatment for European approval later this year after trials showed it to cut …

Biocair appoints new business development managers

June 16, 2011
Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

Biocair has appointed two new business development managers, Natalie Gerrard and Steve Taylor. Natalie Gerrard was promoted internally from within …

Sanofi headquarters

Sanofi signs regenerative medicines collaboration

June 16, 2011
Research and Development Audion, Sanofi, hearing loss

Sanofi has signed a research pact with Audion Therapeutics to develop regenerative medicines for hearing loss. The companyโ€™s two-year deal …

The Gateway to Local Adoption Series

Latest content